These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
203 related items for PubMed ID: 31969173
1. Effects of inhaled nitric oxide for postoperative hypoxemia in acute type A aortic dissection: a retrospective observational study. Zhang H, Liu Y, Meng X, Yang D, Shi S, Liu J, Yuan Z, Gu T, Han L, Lu F, Xu Z, Liu Y, Yu M. J Cardiothorac Surg; 2020 Jan 22; 15(1):25. PubMed ID: 31969173 [Abstract] [Full Text] [Related]
2. Nitric Oxide Inhalation Therapy Attenuates Postoperative Hypoxemia in Obese Patients with Acute Type A Aortic Dissection. Zheng P, Jiang D, Liu C, Wei X, Li S. Comput Math Methods Med; 2022 Jan 22; 2022():9612548. PubMed ID: 35360551 [Abstract] [Full Text] [Related]
3. Inhaled epoprostenol vs inhaled nitric oxide for refractory hypoxemia in critically ill patients. Torbic H, Szumita PM, Anger KE, Nuccio P, LaGambina S, Weinhouse G. J Crit Care; 2013 Oct 22; 28(5):844-8. PubMed ID: 23683572 [Abstract] [Full Text] [Related]
12. Evaluation of inhaled nitric oxide (iNO) treatment for moderate-to-severe ARDS in critically ill patients with COVID-19: a multicenter cohort study. Al Sulaiman K, Korayem GB, Altebainawi AF, Al Harbi S, Alissa A, Alharthi A, Kensara R, Alfahed A, Vishwakarma R, Al Haji H, Almohaimid N, Al Zumai O, Alrubayan F, Asiri A, Alkahtani N, Alolayan A, Alsohimi S, Melibari N, Almagthali A, Aljahdali S, Alenazi AA, Alsaeedi AS, Al Ghamdi G, Al Faris O, Alqahtani J, Al Qahtani J, Alshammari KA, Alshammari KI, Aljuhani O. Crit Care; 2022 Oct 03; 26(1):304. PubMed ID: 36192801 [Abstract] [Full Text] [Related]
13. Multicenter randomized controlled trial of the effects of inhaled nitric oxide therapy on gas exchange in children with acute hypoxemic respiratory failure. Dobyns EL, Cornfield DN, Anas NG, Fortenberry JD, Tasker RC, Lynch A, Liu P, Eells PL, Griebel J, Baier M, Kinsella JP, Abman SH. J Pediatr; 1999 Apr 03; 134(4):406-12. PubMed ID: 10190913 [Abstract] [Full Text] [Related]
14. Implementation of an inhaled nitric oxide protocol decreases direct cost associated with its use. Todd Tzanetos DR, Housley JJ, Barr FE, May WL, Landers CD. Respir Care; 2015 May 03; 60(5):644-50. PubMed ID: 25650437 [Abstract] [Full Text] [Related]
15. Nitric oxide versus epoprostenol for refractory hypoxemia in Covid-19. Poonam PBH, Koscik R, Nguyen T, Rikhi S, Lin HM. PLoS One; 2022 May 03; 17(6):e0270646. PubMed ID: 35759496 [Abstract] [Full Text] [Related]
17. Noninferiority of Inhaled Epoprostenol to Inhaled Nitric Oxide for the Treatment of ARDS. Ammar MA, Bauer SR, Bass SN, Sasidhar M, Mullin R, Lam SW. Ann Pharmacother; 2015 Oct 03; 49(10):1105-12. PubMed ID: 26187741 [Abstract] [Full Text] [Related]
18. Inhaled nitric oxide and postoperative outcomes in cardiac surgery with cardiopulmonary bypass: A systematic review and meta-analysis. Yan Y, Kamenshchikov N, Zheng Z, Lei C. Nitric Oxide; 2024 May 01; 146():64-74. PubMed ID: 38556145 [Abstract] [Full Text] [Related]